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Abstract 
Pharmacists’ roles in provision of family planning products is expanding in the United States (U.S.).  This article details established as 
well as emerging roles for U.S. pharmacists in the provision of contraception. These include helping patients develop reproductive life 
plans; dispensing prescription contraceptive products and counseling patients; assisting and educating patients with non-prescription 
contraceptive products, including emergency contraception; participating in collaborative practice agreements; administering 
contraception products; and making referrals and developing partnerships.  The provision of contraception in the U.S. is dynamic, and 
pharmacists should continue to be aware of changes that will impact them professionally. As approximately 45% of pregnancies in 
the U.S. are unintended, through these roles pharmacists can impact an important public health priority. 
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Background 
Approximately 45% of all pregnancies in the United States (U.S.) 
are unintended.  “Unintended” pregnancies refer to pregnancies 
which the woman reports to have desired later (“mistimed” 
pregnancy) or never (“unwanted” pregnancy).  Unintended 
pregnancies have been associated with adverse pregnancy 
outcomes including premature birth and delayed entry into 
prenatal care.1 As unintended pregnancies have a significant 
impact on public health, objectives to reduce the unintended 
pregnancy rate are included in Healthy People 2020.2  
 
Due to their accessibility and expertise, pharmacists are well-
positioned to address this public health priority. Indeed, 
pharmacists’ roles in the provision of family planning products 
and counseling is expanding in the U.S. This article focuses on 
established and emerging roles for U.S. pharmacists in family 
planning. 
 
Roles for pharmacists in family planning 
There are many potential roles for U.S. pharmacists in family 
planning (Table 1).  Some roles are well-established, in that 
pharmacists have been traditionally providing these services 
and have familiarity with them.  Other roles are emerging, 
which may require pharmacists to adapt or expand current 
practice. 
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Developing reproductive life plans 
One way in which pharmacists can make an impact is by helping 
patients to develop a reproductive life plan (RLP).  A RLP 
includes goals patients make personally about having or not 
having children and encourages intentional pregnancy planning.  
Both male and female patients should be counseled about their 
RLP, to consider if and when they would like to have children.3 
Based on patient preferences, pharmacists can then help 
patients determine whether contraception is needed and which 
type is most appropriate.  Pharmacists can counsel patients on 
optimal birth spacing (18-59 months from a woman’s last 
delivery and conception of next pregnancy).4 Pharmacists can 
also use the RLP to raise awareness with patients on the impact 
of current behaviors on their health, future fertility, and birth 
outcomes.3 RLPs should be routinely offered as part of primary 
care and revisited periodically, as a patient’s goals may change 
throughout life.5 
 
To create the RLP, patients should answer a series of open-
ended questions.5 To initiate the conversation, pharmacists may 
use an opening such as “I’d like to ask you a few questions that 
may not seem related to the reason for your visit. We ask these 
questions of everyone, to help us provide quality, preventive 
health care.”3 Another way to approach patients on the topic of 
family planning is through the One Key Question® (OKQ). 6 The 
OKQ involves asking all patients of childbearing potential 
“Would you like to become pregnant in the next year?”6 A 
variation of the question is “Are you considering pregnancy in 
the next year, or could you possibly become pregnant?” After 
asking about whether the patient plans to have any children in 
the future, pharmacists can ask follow-up questions regarding 
the number and timing of pregnancies, patient behaviors, and 
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family history. Pharmacists can then discuss appropriate 
contraceptive methods based on patient preferences and 
encourage action by asking specific questions on how the 
patient plans to implement the methods.5 The Centers for 
Disease Control and Prevention (CDC) have sample tools for 
providers and patients posted to their website that guides one 
through the RLP process;5 many state and local health 
departments and health plans have tools as well, some of which 
provide more detail than the CDC’s.7,8 
 
Dispensing prescription contraceptive products and counseling 
patients 
When dispensing prescription contraceptives and emergency 
contraceptives, pharmacists have a key opportunity to educate 
patients about the products to ensure appropriate use, assess 
adherence, address possible drug interactions, and monitor 
adverse effects.  This counseling should occur for new and refill 
prescriptions.9  As current data indicate that approximately half 
of all unintended pregnancies occur among couples using some 
form of contraception in the month prior to conception,1  the 
importance of the pharmacist educating patients on correct and 
consistent use cannot be overstated. 
 
There are also changes to insurance coverage and financing of 
contraceptives that pharmacists may need to be aware of at the 
time of dispensing. In 2000, the Equal Employment Opportunity 
Commission deemed it unlawful for plans to deny coverage for 
contraceptives if they covered other preventive prescription 
medications and services.10 Federal law has since required state 
Medicaid programs to cover family planning services and 
supplies. In 2010, the Affordable Care Act (ACA) required 
private plans to cover a broad array of recommended 
preventive services, without cost to policy holders. In alignment 
with recommendations from the Institute of Medicine, the 
Health Resources and Services Administration defined 
preventive service as all Food and Drug Administration (FDA)-
approved contraceptive methods and patient counseling for 
women with reproductive ability, as prescribed by a health care 
provider.10 Therefore, private plans must cover at least one of 
each of the different types of FDA-approved oral 
contraceptives, without cost sharing to the patient.  
 
Insurance companies can improve access to oral contraceptives 
by increasing the dispensing period of contraceptives to 12 
months per prescription. Compared to women receiving a one 
to three month supply, women who receive a one year supply 
have been found to be 30% less likely to have an unintended 
pregnancy.11 At the time of this writing, laws requiring 
insurance companies to pay for 12 months of oral 
contraceptives when first prescribed have been passed in 
Oregon, Washington D.C., and Vermont with similar legislation 
in progress in many other states.10  
  
Assisting and educating patients with non-prescription 
contraceptive products, including emergency contraception 
Pharmacists play an important role for patients seeking 
nonprescription contraceptive products.  Pharmacists can assist 
in the selection of a product that will meet a patient’s needs 
and medical history and then provide education about the 
product to ensure correct and consistent use.9 Pharmacies are 
also important sources of over-the-counter (OTC) emergency 
contraception (EC) products for patients.  Additionally, 9 states 
at the time of this writing allow for pharmacists to prescribe EC 
as part of collaborative practice agreements (CPA) and/or after 
continuing education (CE).12 Pharmacists also have key roles in 
counseling on the use of EC and either providing a prescription 
for regular contraception (per state law) or providing a referral 
for a patient to obtain a regular contraceptive method from her 
prescriber.  Pharmacists can also provide referrals to patients 
for whom the intrauterine copper contraceptive is the best 
choice for emergency contraception. 
 
Pharmacist-initiated prescriptions for contraception  
Pharmacists in some states can issue prescriptions for hormonal 
contraception as part of statewide protocols. At the time of this 
writing, two states (California, Oregon) have passed legislation 
permitting pharmacists to do so, 13, 14 and other states are 
considering similar legislation.15 Blood pressure measurement 
and a thorough medical history to identify possible 
contraindications are the only screenings that must be 
performed before provision of hormonal contraception. 
Additional physical assessment, such as clinical breast 
examinations or pelvic examinations, are not considered 
necessary to safely initiate hormonal contraception.16,17  As 
pharmacists have the training necessary to obtain a blood 
pressure measurement and collect a patient history, they are 
able to establish whether a patient is eligible for hormonal 
contraceptive therapy.9,17  Pharmacists can select the 
appropriate therapy based on patient needs, counsel her on use 
and possible adverse effects, and monitor outcomes.9  Allowing 
women to obtain hormonal contraception directly at the 
pharmacy removes many barriers and should facilitate initiation 
and maintenance of the prescription. Additionally, women with 
health coverage that pays for contraception will be able to 
receive the product with no cost-sharing, since the pharmacist 
is generating a prescription.18 
 
In the Oregon protocol, pharmacists complete a 5-hour CE 
program.  At the pharmacy, a female patient aged 18 years or 
older seeking contraceptive therapy completes a self-
assessment questionnaire about her medical history and last 
appointment with a women’s health provider to inform the 
pharmacist’s decision. (Pharmacists cannot initiate a 
prescription for contraception for a patient who has not seen a 
women’s health provider in more than 3 years.)19  Following the 
process outlined in an algorithm, the pharmacist determines 
whether the patient is an appropriate candidate for hormonal 
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contraception (oral or transdermal) to be prescribed and 
dispensed at the pharmacy or if she should be referred for 
additional assessment.20,21  Patients can receive up to a 3 month 
supply for a first fill or a 12-month supply for an established 
prescription at one time.22  Preliminary data from one 
pharmacy chain in Oregon have shown that about 90% of 
women who attempted to receive a prescription at the 
pharmacy were able to do so; 10% of women who presented at 
the pharmacy required a referral.23 At the end of the encounter, 
the pharmacist provides the patient with an information sheet, 
that either details the prescription that was dispensed that day 
or information that a referral is needed.19  Patients under age 
18 years must obtain their first prescription for a hormonal 
contraceptive from a prescriber, but pharmacists can renew 
subsequent prescriptions.  The Oregon legislature plans to 
review this stipulation in five years to determine whether the 
age restriction should be lifted.18 
 
The California law allows pharmacists to prescribe hormonal 
contraception including the pill, patch, ring, or injectable forms 
and does not have any age restrictions.  The pharmacist must 
notify the patient’s primary care provider or enter information 
into a patient record system shared with that provider 
regarding any drugs or devices furnished.  If the patient does 
not have a primary care provider, the pharmacist provides the 
patient with written information regarding the product and 
urges the patient to consult a physician.   Pharmacists wanting 
to participate in the program will need to complete a 1-hour CE 
program.  Otherwise, the protocol is similar to Oregon’s in that 
the pharmacist uses information from a self-assessment 
questionnaire and blood pressure check to determine eligibility 
for the patient to receive hormonal contraception directly from 
the pharmacy.13,22 
 
Participating in collaborative practice agreements (CPA) 
At the time of this writing, 48 states and the District of 
Columbia allow for pharmacists to enter into CPA.  Through 
CPA, pharmacists establish a formal practice relationship with 
another healthcare provider.  Certain patient care services can 
be provided by the pharmacist for patients in the healthcare 
provider’s practice.  While state laws vary, generally through a 
CPA a pharmacist may be able to initiate or modify drug 
therapy, order and interpret lab results related to drug therapy, 
or perform physical assessment.  Collaborative drug therapy 
management (CDTM) is one service that a pharmacist may 
provide through a CPA, and sometimes these terms are used 
synonymously.23 
 
Pharmacists practicing in a CPA may be able to initiate or 
modify hormonal contraception for patients, if specified.  In 
some areas such as Washington state and Washington, DC, for 
example, CPA may include pharmacist-initiated contraception 
as one of the services.24   In Washington state, stickers and signs 
will be utilized in pharmacies to advertise the availability of 
such services.25  Additional states, such as Tennessee, are 
considering expansion of CPA to include contraception.26  
Pharmacist provision of oral contraception through CPA has 
been demonstrated to be successful, with satisfaction for the 
service reported by patients and pharmacists.27 
 
Administering contraception products  
Depending on a state’s scope of practice, pharmacists may be 
able to administer contraception products, specifically 
medroxyprogesterone acetate injections (DMPA).  Pilot studies 
in California and North Carolina examined the impact of 
pharmacist-provided DMPA reinjection.  Both studies concluded 
that the practice was feasible and acceptable.28,29  A survey of 
state boards of pharmacy in the U.S. published in 2012 found 
that in 21 states pharmacists had the ability to administer 
injectable medications other than vaccines as part of CPA, 
board certification, or other broad privileges.30  Moreover, 
many pharmacists already provide injections as part of 
immunization delivery and have training on the technique.  
Amending states’ scope of practice to allow for pharmacist 
administration of injectable medications, including DMPA, 
represents an opportunity for pharmacists to expand practice 
and provide contraception to more populations. 
 
Making referrals and developing partnerships  
As pharmacies often are accessible to many patients through 
their convenient locations and hours of operation, they play a 
key function in clinical-community linkages.31  In regards to 
family planning specifically, these linkages can be formed 
through partnerships with health departments, family planning 
programs, and clinics that provide reproductive health 
services.9 As detailed above, pharmacists may need to refer 
patients seeking contraception or some forms of EC to 
providers outside of the pharmacy.  In addition, pharmacists 
can be sources of information and referral for long-acting 
reversible contraception (LARC), such as intrauterine devices or 
implants.9,32  Due to their high rates of effectiveness, there has 
been more emphasis recently on the promotion of LARC, 
especially in adolescent populations for which they are 
considered first-line therapy.33,34  Pharmacists can dispel 
misconceptions about use of LARC (such as risk of infertility) by 
providing factual information about the products and can aid 
patients requesting such products through referrals.9,33  
Pharmacists can also provide referrals for patients in need of 
other reproductive health services such as clinical breast exams 
or pelvic exams.  
 
Pharmacists can serve as educational resources for patients.  
For example, a study conducted in Iowa examined the use of 
social marketing materials displayed in pharmacies to increase 
knowledge and use of contraceptive options.9  Pharmacists can 
also create “youth-friendly” services and foster an atmosphere 
where adolescents feel comfortable to seek information on 
reproductive health needs, including pregnancy prevention.9,34  
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Other educational opportunities for all patient age groups can 
be developed and delivered in the community at schools, health 
fairs, or other locations, perhaps in collaboration with health 
departments.9 
 
Issues on the horizon 
There are other issues regarding contraception on the horizon 
that pharmacists should be aware of. To increase the access 
and use of contraception, the American Academy of Family 
Physicians and the American Congress of Obstetricians and 
Gynecologists have suggested making contraceptives available 
over the counter. The change from prescription to OTC status 
requires FDA review to ensure specific criteria are met, which 
can take approximately three or four years.10 The ACA currently 
requires no-cost coverage for prescription contraceptives; 
legislation has been introduced by members of Congress to 
allow coverage to include non-prescribed, or OTC, 
contraceptives. Beginning in January 2018, Maryland will be the 
first state to require insurers to cover OTC contraceptives 
(without a prescription), with the same cost-sharing guidelines 
that apply to prescription products.10  
 
Another potential endeavor to increase access to 
contraceptives focuses on online services or web applications 
that allow patients to interact with providers by video, obtain 
prescriptions, and enroll in mail-order prescription delivery. 
Nurx, Maven, and Planned Parenthood’s application are all 
services that currently exist that allow individuals to participate 
in telemedicine programs.10  
 
The provision of contraception in the U.S. is dynamic.  
Pharmacists should continue to be aware of changes that will 
impact them professionally. Table 2 outlines resources 
pharmacists can consult regarding issues such as state scope of 
practice for contraception and emergency contraception. 
 
Conclusion 
There are many important responsibilities for pharmacists when 
aiding patients with contraception. Whether performing 
traditional or emerging roles, pharmacists should ensure 
patients have the best method for them and understand how to 
accurately and consistently use the method.  Through these 
practices, pharmacists can help to reduce the rate of 
unintended pregnancies and to improve outcomes for their 
patients. 
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Table 1. Potential roles for pharmacists in family planning 
 
 
• Helping patients develop reproductive life plans 
• Dispensing prescription contraceptive products and counseling patients 
• Assisting and educating patients with non-prescription contraceptive products, including emergency contraception 
• Participating in collaborative practice agreements 
• Administering contraception products 
• Making referrals and developing partnerships 
 
 
 
 
Table 2.  Resources to consult for current information on contraception and pharmacists 
 
 
• Centers for Disease Control and Prevention. Contraception. Available from: 
http://www.cdc.gov/reproductivehealth/unintendedpregnancy/contraception.htm 
 
• Guttmacher Institute. State policies in brief: Emergency contraception. Available from: 
https://www.guttmacher.org/sites/default/files/pdfs/spibs/spib_EC.pdf  
 
• Kaiser Family Foundation. Women’s health policy. Available from: http://www.kff.org/womens-health-policy/    
 
• National Alliance of State Pharmacy Associations.  State Policy. Available from: http://www.naspa.us/restopic/state-policy/ 
 
• National Alliance of State Pharmacy Associations. Statewide protocols for pharmacist prescribing. Available from: 
http://www.naspa.us/resource/statewide-protocols-for-pharmacist-prescribing/  
 
• National Conference of State Legislatures. Emergency contraception state laws. Available from: 
http://www.ncsl.org/research/health/emergency-contraception-state-laws.aspx 
 
• National Conference of State Legislatures. Insurance coverage for contraception laws. Available from: 
http://www.ncsl.org/research/health/insurance-coverage-for-contraception-state-laws.aspx  
 
 
 
